Global

Pharmaceutical Sciences Experts

Jonathan Dimmock

Professor
Pharmacy
University of Saskatchewan
Canada

Biography

Dr. Dimmock is a medicinal chemist. He obtained his Ph. D. on the syntheses of candidate narcotic analgesics from the University of London, England and then worked as a research chemist in the industrial sector in the U.K. He joined the faculty of the College of Pharmacy (as it was then) in 1967 and rose to be a full professor in 1976. His teaching was principally devoted to a required course in medicinal chemistry and he initiated an elective on drug design. Much of this latter course was incorporated into a book entitled “An Introduction to Drug Design” which was published in 1997. In 1998 Dr. Dimmock received the University of Saskatchewan Students’ Union Teaching Excellence Award. In 2002 Dr. Dimmock retired in order to work full time in research principally in conjunction with Dr. Umashankar Das.

Research Interest

The research emphasis of Dr. Dimmock continues to be in the realm of cancer chemotherapy. In practice novel compounds are designed as anticancer drugs which are then synthesised and evaluated for their bioactivity. Specifically the principal group of molecules examined are conjugated unsaturated ketones which have an affinity for thiols and not amino and hydroxyl groups which are found in nucleic acids. An aim is to prepare compounds which demonstrate tumour-selective toxicity which are also effective against multidrug resistant tumours. Use is made of computer software packages which enables the shapes of active and inactive molecules to be compared as well as docking compounds to ascertain the extent of binding of molecules at a binding site of a specific enzyme. The modes of action of bioactive compounds are studied and in particular the effects of the novel compounds on mitochondrial function are noted. X-ray crystallography of representative molecules is undertaken to confirm the proposed structures and to reveal the shapes of molecules.

Publications

  • Panda AK, Das U, Roayapalley PK, Sakagami H, Kawase M, Balzarini J, De Clercq E, Dimmock JR. Niacin esters of chalcones with tumor-selective properties. Journal of enzyme inhibition and medicinal chemistry. 2016 Nov 1;31(6):1451-6.

  • Santiago-Vázquez Y, Das U, Varela-Ramirez A, T Baca S, Ayala-Marin Y, Lema C, Das S, Baryyan A, R Dimmock J, J Aguilera R. Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/lymphoma cells. Clinical cancer drugs. 2016 Oct 1;3(2):138-46.

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America